Abstract
As a treatment modality for malign and certain non-malignant diseases, photodynamic therapy (PDT) involves a two step protocol which consists of the (selective) uptake and accumulation of a photosensitizing agent in target cells and the subsequent irradiation with light in the visible range. Reactive oxygen species (ROS) produced during this process cause cellular damage and, depending on the treatment dose / severity of damage, lead to either cellular repair / survival, apoptotic cell death or necrosis. PDT-induced apoptosis has been focused on during the last years due to the intimate connection between ROS generation, mitochondria and apoptosis; by this PDT employs mechanisms different to those in the action of radio- and chemotherapeutics, giving rise to the chance of apoptosis induction by PDT even in cells resistant to conventional treatments. In this review, the (experimental) variables determining the cellular response after PDT and the known mechanistic details of PDT-triggered induction and execution of apoptosis are discussed. This is accompanied by a critical evaluation of wide-spread methods employed in apoptosis detection with special respect to in vitro / cellbased methodology.
Keywords: photodynamic therapy, anticancer treatment, apoptosis, cell death, apoptosis detection methods
Current Pharmaceutical Design
Title: Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection
Volume: 11 Issue: 9
Author(s): Kristjan Plaetzer, Tobias Kiesslich, Christian Benno Oberdanner and Barbara Krammer
Affiliation:
Keywords: photodynamic therapy, anticancer treatment, apoptosis, cell death, apoptosis detection methods
Abstract: As a treatment modality for malign and certain non-malignant diseases, photodynamic therapy (PDT) involves a two step protocol which consists of the (selective) uptake and accumulation of a photosensitizing agent in target cells and the subsequent irradiation with light in the visible range. Reactive oxygen species (ROS) produced during this process cause cellular damage and, depending on the treatment dose / severity of damage, lead to either cellular repair / survival, apoptotic cell death or necrosis. PDT-induced apoptosis has been focused on during the last years due to the intimate connection between ROS generation, mitochondria and apoptosis; by this PDT employs mechanisms different to those in the action of radio- and chemotherapeutics, giving rise to the chance of apoptosis induction by PDT even in cells resistant to conventional treatments. In this review, the (experimental) variables determining the cellular response after PDT and the known mechanistic details of PDT-triggered induction and execution of apoptosis are discussed. This is accompanied by a critical evaluation of wide-spread methods employed in apoptosis detection with special respect to in vitro / cellbased methodology.
Export Options
About this article
Cite this article as:
Plaetzer Kristjan, Kiesslich Tobias, Oberdanner Benno Christian and Krammer Barbara, Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection, Current Pharmaceutical Design 2005; 11 (9) . https://dx.doi.org/10.2174/1381612053507648
DOI https://dx.doi.org/10.2174/1381612053507648 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bugs as Drugs: Understanding the Linkage between Gut Microbiota and
Cancer Treatment
Current Drug Targets Anticancer and Cytotoxic Activities of [Cu(C6H16N2O2)2][Ni(CN)4] and [Cu(C6H16N2O2)Pd(CN)4] Cyanidometallate Compounds on HT29, HeLa, C6 and Vero Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism An Overview of Emerging Immunotargets of Genitourinary Tumors
Current Drug Targets Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
CNS & Neurological Disorders - Drug Targets Clinical Use of Therapies Targeting Tumor Vasculature and Stroma
Current Cancer Drug Targets Advances in On-line Absolute Trace Gas Analysis by SIFT-MS
Current Analytical Chemistry PET with Non-Standard Nuclides
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member:
Recent Patents on Anti-Infective Drug Discovery Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors
Current Topics in Medicinal Chemistry The Rational Design of Anticancer Platinum Complexes: The Importance of the Structure-Activity Relationship
Current Medicinal Chemistry Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease
Current Vascular Pharmacology Perinatal Management of Fetal Tumors
Current Pediatric Reviews Apoptotic and Antiproliferative Potential of GAPDH from <i>Mallotus philippensis</i> Seed on Human Lung Carcinoma: <i>In Vitro</i> and <i>In Vivo</i> Approach
Protein & Peptide Letters Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance
Recent Patents on Cardiovascular Drug Discovery